These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15313588)

  • 21. Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects.
    Shipp A; Lawrence G; Gentry R; McDonald T; Bartow H; Bounds J; Macdonald N; Clewell H; Allen B; Van Landingham C
    Crit Rev Toxicol; 2006; 36(6-7):481-608. PubMed ID: 16973444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Literature review on the genotoxicity, reproductive toxicity, and carcinogenicity of ethyl methanesulfonate.
    Gocke E; Bürgin H; Müller L; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):254-65. PubMed ID: 19857796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of non-genotoxic carcinogenesis in rats using changes in gene expression following acute dosing.
    Nioi P; Pardo ID; Sherratt PJ; Snyder RD
    Chem Biol Interact; 2008 Apr; 172(3):206-15. PubMed ID: 18328469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transplacental carcinogenicity of 3'-azido-3'-deoxythymidine in B6C3F1 mice and F344 rats.
    Walker DM; Malarkey DE; Seilkop SK; Ruecker FA; Funk KA; Wolfe MJ; Treanor CP; Foley JF; Hahn FF; Hardisty JF; Walker VE
    Environ Mol Mutagen; 2007; 48(3-4):283-98. PubMed ID: 17358026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perinatal carcinogenesis: biologic curiosity or practical necessity?
    Clayson DB
    Natl Cancer Inst Monogr; 1979 May; (51):235-8. PubMed ID: 481576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of evidence from short-term studies leading to the prediction that diazoaminobenzene (1,3-diphenyltriazine) is a carcinogen.
    Bordelon NR; Chhabra R; Bucher JR
    J Appl Toxicol; 2005; 25(6):514-21. PubMed ID: 16158390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current criteria to establish human carcinogens.
    Cogliano VJ
    Semin Cancer Biol; 2004 Dec; 14(6):407-12. PubMed ID: 15489133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revisiting alternative approaches to the assessment of carcinogenic risk.
    Downes N
    Toxicol Pathol; 2010 Feb; 38(2):324-7. PubMed ID: 20124498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Problems and perspectives in perinatal carcinogenesis: a summary of the conference.
    Rice JM
    Natl Cancer Inst Monogr; 1979 May; (51):271-8. PubMed ID: 225670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer dose--response assessment for acrylonitrile based upon rodent brain tumor incidence: use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity.
    Kirman CR; Gargas ML; Marsh GM; Strother DE; Klaunig JE; Collins JJ; Deskin R
    Regul Toxicol Pharmacol; 2005 Oct; 43(1):85-103. PubMed ID: 16099568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of the rodent carcinogenicity of 60 pesticides by the DEREKfW expert system.
    Crettaz P; Benigni R
    J Chem Inf Model; 2005; 45(6):1864-73. PubMed ID: 16309294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revised assessment of cancer risk to dichloromethane II. Application of probabilistic methods to cancer risk determinations.
    David RM; Clewell HJ; Gentry PR; Covington TR; Morgott DA; Marino DJ
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):55-65. PubMed ID: 16439044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages.
    Brent RL
    Birth Defects Res B Dev Reprod Toxicol; 2004 Oct; 71(5):303-20. PubMed ID: 15505806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of quantitative structure-activity relationship (QSAR) models to predict the carcinogenic potency of chemicals I. Alternative toxicity measures as an estimator of carcinogenic potency.
    Venkatapathy R; Wang CY; Bruce RM; Moudgal C
    Toxicol Appl Pharmacol; 2009 Jan; 234(2):209-21. PubMed ID: 18977375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thiazopyr and thyroid disruption: case study within the context of the 2006 IPCS Human Relevance Framework for analysis of a cancer mode of action.
    Dellarco VL; McGregor D; Berry SC; Cohen SM; Boobis AR
    Crit Rev Toxicol; 2006; 36(10):793-801. PubMed ID: 17118729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of potential human carcinogenicity of the synthetic monomer ethyl acrylate.
    Williams GM; Iatropoulos MJ
    Regul Toxicol Pharmacol; 2009 Feb; 53(1):6-15. PubMed ID: 18930102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Veterinary drugs no longer need testing for carcinogenicity in rodent bioassays.
    Galer DM; Monro AM
    Regul Toxicol Pharmacol; 1998 Oct; 28(2):115-23. PubMed ID: 9927561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transplacental lung carcinogenesis: molecular mechanisms and pathogenesis.
    Miller MS
    Toxicol Appl Pharmacol; 2004 Jul; 198(2):95-110. PubMed ID: 15236948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Animal carcinogenicity studies: implications for the REACH system.
    Knight A; Bailey J; Balcombe J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():139-47. PubMed ID: 16555967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The transgenic mouse assay as an alternative test method for regulatory carcinogenicity studies--implications for REACH.
    Wells MY; Williams ES
    Regul Toxicol Pharmacol; 2009 Mar; 53(2):150-5. PubMed ID: 19126422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.